Stock ADK DIAGNOS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights DIAGNOS Inc.

Equities

ADK

CA2524423068

Delayed Toronto S.E.
Other stock markets
 19:58:06 10/05/2024 BST 		5-day change 1st Jan Change
0.3 CAD 0.00% Intraday chart for DIAGNOS Inc. -6.25% -25.93%
05-06 Diagnos Inc. Announces to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024 CI
04-16 DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Diagnos Inc. Announces to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
CI
DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification
CI
Diagnos Raises C$182,000 in the Final Tranche of a Private Placement of Share Units
MT
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Diagnos Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica
MT
Diagnos Inc. Secures Exclusive Distribution Agreement for Canada with Essilorluxottica
CI
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
DIAGNOS Inc. Announces Commencement of its Innovative Deployment in an Advanced Screening Program At Canada's Presented Specialist Care Provider in Diabetes and Endocrinology
CI
DIAGNOS Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
DIAGNOS Inc. and IRIS, The Visual Group Strengthens Partnership with the Launch of "IRIS-ai Powered by DIAGNOS"
CI
Diagnos and ETS Unveil Method to Adapt Deep Learning Algorithms
MT
DIAGNOS and ETS to Present Research on Mass Screening for Macular Edema at ARVO 2023
CI
Diagnos Gets OK For the Use of Diabetic Retinopathy Screening Technology in Quebec Hospitals
MT
Diagnos Inc Gets the Green Light for the Use of Its Diabetic Retinopathy Screening Technology in Quebec Hospitals
CI
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Diagnos Enters Retinal Diagnostics Market With New 3D Image Analysis Technology
MT
DIAGNOS Inc. Enters the Retinal Diagnostics Market with Its New 3D Image Analysis Technology
CI
DIAGNOS Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADK Stock
  4. News DIAGNOS Inc.
  5. Highlights